Addressing challenges in information-provision: a qualitative study among oncologists and women with advanced breast cancer by Vliet, L.M. van et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2021-11-02 and may be subject to
change.




in information-provision: a qualitative study 
among oncologists and women with advanced 
breast cancer
Liesbeth M. van Vliet1,2*, Maartje C. Meijers1, Sandra van Dulmen3,4,5, Elsken van der Wall6, Nicole Plum6, 
Jacqueline Stouthard7 and Anneke L. Francke3,8 
Abstract 
Background: There is a need for more insight into how to address challenges of information-provision for women 
with advanced breast cancer. We aimed to explore oncologists’ and patients’ views on (i) the challenges of informa-
tion-provision, and (ii) possible strategies to address these challenges, meanwhile (iii) exploring the possible facilitat-
ing role of positive expectations and empathy.
Methods: Semi-structured interviews were held with oncologists (n = 10) and women with advanced breast cancer 
(n = 14). Principles of Thematic Analysis were followed, with two researchers analyzing transcribed data, supported by 
Atlas.ti software.
Results: Taken together the data from oncologists and patients, we found that when communicating with patients 
with advanced cancer, oncologists face challenges, including handling patients’ unrealistic disease (status) beliefs, and 
choosing approaches for discussing available treatment options and their side effects. Possible strategies to address 
these challenges include balancing information with acceptance of denial, and using medical expertise to guide 
treatment discussions. A sensitive issue is whether to discuss the option of no anti-cancer treatment. Meanwhile, 
approaches and preferences for discussions of side effects vary. Positive expectations and empathy can facilitate 
information-provision by creating space and helping patients to open up more.
Conclusions: Integrating oncologists’ and patients’ views, oncologists can provide realistic information while also, 
temporarily, accepting denial, and can use their medical expertise to address challenges around unrealistic beliefs 
and discussion of treatment options. Finding ways to tailor discussions of no anti-cancer treatment and side-effect 
information are needed. Positive expectations and empathy might facilitate – tailored – information-provision, leading 
ultimately to patient-centered care lying at the heart of medicine.
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Introduction
Good information-provision is fundamental to patient-
centered decisions and care, especially when being faced 
with an advanced cancer diagnosis [1]. When patients 
feel better informed, they experience more person-cen-
tered care [1], i.e. care that is respectful of individual 
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preferences, needs and values [2]. Breast cancer patients 
are, however, increasingly confronted with complex 
information, as scientific advances continue to reveal 
the heterogeneity of breast cancer, leading to many sub-
types with various treatments options [3,  4]. To make 
individual, well-balanced, decisions, patients need to be 
informed not only about the incurability of their disease, 
but also about the available treatment options and their 
potential advantages and disadvantages.
Full information-provision is, however, not always 
achieved; nor may it always be desirable. More specifi-
cally, patients are not always explicitly informed about 
the incurability of their illness [5, 6], or about all available 
treatment options and potential side effects [5–7]. Doc-
tors sometimes omit the option of no anti-cancer ther-
apy [5–7], and the possibly negative effects of treatment 
on condition and social functioning [5, 8]. Although the 
lack of full information-provision can limit informed 
decision-making, some patients are also reluctant to 
receive all information [9, 10], especially as their illness 
progresses [11, 12]. In order to inform patients without 
overwhelming them, we need to shift our focus beyond 
current practices and preferences, to a deeper under-
standing of the challenges oncologists and patients per-
ceive in information-provision (about disease status, 
available treatment options, and side effects), and possi-
ble strategies to address these challenges.
Moreover, specific ways to facilitate information-provi-
sion need to be explored. Promising techniques include 
communication strategies based on placebo-effect princi-
ples, such as positive expectations and empathy. Positive 
expectations can decrease patients’ pain perceptions [13, 
14], while empathic behaviors (e.g., reassurance, attentive 
silence) can decrease anxiety and increase recall [15–19]. 
The potential of positive expectations and empathy to 
facilitate information-provision has yet to be explored.
Against this background, the aim of this project is to 
explore, in the setting of advanced breast cancer, oncolo-
gists’ and patients’ views on (i) the challenges of informa-
tion-provision and (ii) possible strategies to address these 
challenges, while (iii) exploring the possible facilitating 
role of positive expectancies and empathy in addressing 
the challenges. Addressing these aims will help achieve 
optimal information-provision and person-centered care.
Methods
Design
Qualitative study, using semi-structured interviews with 
breast cancer patients and oncologists.
Ethical considerations
All study-procedures were submitted to the Medical 
Ethical Committee of the Netherlands Cancer Institute 
(NKI-AVL), which exempted the study from formal ethi-
cal approval (P18LVW). In addition, the Ethical Com-
mittee of Leiden University, Psychology Department, 
approved the conduct of the study. The participating hos-




Female patients (> 18 years) with incurable breast cancer; 
sufficient command of Dutch language; cognitively able 
to provide consent and be interviewed.
Oncologists




We followed principles of purposeful sampling, aiming a 
variety in participants’ age, disease characteristics, geo-
graphical location, education, cultural background.
Participants were recruited – June-Sept 2019 – through 
the Dutch breast cancer patient advocacy organization 
and a patient organization for migrant women, involved 
patient-representatives, snowballing procedures. Via per-
sonal contacts and oncologists within the participating 
hospital we purposefully recruited patients with a non-
Western migrant background and/or low educational 
levels. Patients contacted the research team, who pro-
vided more information via telephone and checked inclu-
sion criteria. An information letter/consent form and 
questionnaire were sent, and interviews were scheduled 
at patients’ homes or at Leiden University. Written con-
sent was obtained pre-interview and the questionnaire 
collected/completed. Patients were informed they could 
always stop the interview.
Oncologists
Recruitment occurred via personalized emails, or – for 
one hospital – via a medical psychologist. Oncologists 
interested in participating contacted the research team 
(LV), who provided more information (via email). The 
information letter/consent form, and questionnaire were 
sent and the interview was scheduled at the oncologist’s 
hospital or by telephone. Written consent was obtained 
pre-interview and the questionnaire collected/completed 
(or sent by post).
Participants were reimbursed only for travel. Tran-
scriptions were offered for comment/corrections.
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Topic list
A topic list was created (Additional file  1), in collabo-
ration with patient-representatives. The topic guide 
focused on i) the challenges of informing patients about 
treatment options, aims and side-effects; ii) strategies 
how these challenges can be overcome; iii) the possible 




Sociodemographic/ disease characteristics were assessed.
Oncologists
Sociodemographic and professional characteristics, and 
self-perceived confidence in discussing disease status 
(treatment aims), options and benefits/side effects in 
advanced cancer were assessed (self-created 1–4 scale).
Data collection
Interviews were held by one – trained/experienced 
female – researcher (LV – communication/palliative 
care/psychology background, or MM – communication/
psychology background), for many interviews both were 
present.
The audio-recorded interviews were transcribed verba-
tim, and personal identifiers removed. Data-analysis was 
part of a cyclical process of data collection and analysis. 
Data collection was stopped when data saturation was 
achieved.
Analysis process
Analysis was performed using Thematic Analysis [20]. 
Firstly, two researchers (LV, MM) (re)read the tran-
scripts to familiarize themselves with the interview data 
and independently wrote a memo of the most striking 
findings of each interview (step 1). These memos were 
subsequently compared and discussed, and initial codes 
were given to relevant interview fragments (step 2). 
Using further discussion of memos and initial codes, 
the two researchers generated themes, which were 
displayed in a draft figure (step 3). At several points, 
themes and interim analyses were reviewed and dis-
cussed with co-authors (backgrounds in psychology/
medicine/nursing/communication) (step 4). Gradually, 
themes were further defined and named, and again dis-
cussed with co-authors (step 5). Lastly, the results sec-
tion was written and the research question answered 
(step 6). Input was received from co-authors, and the 
final figure, displaying the main themes identified, was 
drawn. Steps 2–5 were supported by software program 
Atlas.ti. COREQ guidelines for qualitative research 
were followed for reporting.
Results
Participants
Table  1 shows the background characteristics of the 14 
patients and 10 oncologists included; Fig.  1 shows the 
recruitment process.
Themes
From the analysis of oncologists’ and patients’ data, three 
main themes were identified, concerning challenges in 
the discussion of disease status, treatment options, and 
side effects. Patients often started by mentioning little 
challenges, mainly focusing on their preferences. Oncolo-
gists identified challenges, but considered informing 
patients a core task. Figure 2 displays themes and possi-
ble relations between them.
Challenge 1: How to handle unrealistic disease (status) 
beliefs
Oncologists mentioned the challenge of handling 
patients’ unrealistic disease beliefs. This focused on 
patients not expecting or accepting the disease’s incur-
ability, and having overly optimistic/pessimistic 
expectations.
Strategy chosen by oncologists: informing & accepting
To address this challenge, oncologists try to provide 
information – especially concerning the disease’s incur-
ability – and to keep an open dialogue, actively explor-
ing patients’ perceptions. Simultaneously, they seem to 
accept – temporary – denial of the incurability of the 
disease. If necessary, e.g. with disease progression or if 
decision-making is hampered, this may be re-discussed.
What we often see in clinical practice is that as a 
coping mechanism people say “I hear you [that the 
disease is incurable, red], but I don’t want to accept 
it yet (…). So I’ll say (…) you need to know this to 
make well-informed decisions, but we don’t need to 
keep discussing that you’re dying. (4005).
Patients’ preferences: informing
Patients stressed the importance of being clearly 
informed about their disease status; the incurable status 
is devastating but essential to know.
You’ve got two children; so you don’t want to hear it 
[that the disease is incurable, red]; nobody wants to 
hear that. But well [it needs to be said clearly, ed]; 
they cannot keep avoiding it. (3013).
Page 4 of 12van Vliet et al. BMC Palliat Care          (2021) 20:142 
Table 1 Background characteristics of participants
Patients Total (N = 14)
M (SD)
Age 57.92 (7.40) (Range 46–70)
N (%)
Marital status
Married (including registered partnership) 7 (50.0)
Single (including divorced, widowed, unmarried) 7 (50.0)
Highest Education
Low (primary education or less) -
Intermediate-1 (lower education) 5 (35.7)
Intermediate-2 (upper secondary) 2 (14.3)
High (tertiary) 7 (50.0)
Occupation
Paid job -
Disabled / Sick leave 11 (78.6)
Housewife -
Retired 2 (14.3)








Hormone therapy 1 (7.1)
Immunotherapy 9 (64.3)
Operation 3 (21.4)
Symptom-oriented treatment (e.g. bone strengthening & rehabilitation) 2 (14.3)
Tumor-oriented treatment possible, but refrained from 4 (28.5)
Tumor-oriented treatment impossible 1 (7.1)
Oncologists Total (N = 10)
M (SD)








Specialized cancer hospital 2 (20)
Experience
 < 5 years 2 (20)
5 – 10 years 2 (20)
 > 10 years 6 (60)
Self-perceived confidence to discuss treatment aims
Not at all -
Moderate -
Fairly 1 (10)
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Challenge 2: How to approach discussing available 
treatment options
A second challenge involves discussing treatments 
options, specifically whether to discuss all options or a 
selection, and whether to include the option of no anti-
cancer therapy.
Strategy 1 chosen by oncologists: medical expertise 
and selection is duty
Oncologists, though acknowledging patients’ right to 
know all options, seemed to agree that medical expertise 
and selection is needed. They often select the most effec-
tive options (in terms of e.g. efficacy, limited side effects); 
some select options that differ (e.g. in terms of side 
effects or hospital visits needed); some actively enquire 
about patients’ priorities/expectations.
I generally make a selection. I think most people 
benefit from your advice; that’s why they’re there. I 
generally discuss the most effective treatment (…). 
If there are two equal options, then you discuss the 
pros and cons of the different options. (ID 4028).
Patients’ preferences: medical expertise and selection 
is trusted
Patients often expressed faith in oncologists’ medi-
cal expertise and appreciated them selecting treatment 
options. Most did not want to carry sole responsibility 
a  Women can receive several treatments, so this does not add up to 100%
Table 1 (continued)
Patients Total (N = 14)
Very 9 (90)
Self-perceived confidence to discuss treatment options




Self-perceived confidence to discuss benefits/side effects




Fig. 1 Flowchart of recruitment process of patients and oncologists
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for decision-making, arguing that they lacked medical 
expertise.
I don’t know about all the treatment options there 
are so I trust that the oncologist will give me the best 
treatment (…). He will discuss it with the team; he 
confers with other oncologists and doctors. That’ll 
lead to a specific treatment option, and I assume he 
knows what he’s doing. ( 3034).
Still, some women were keen to make their own deci-
sions and/or wanted an oncologist to respect their 
decisions.
You can also have chemo in tablet form, but because 
I already wasn’t responding well to it, I said I’m not 
doing chemo. And she didn’t try to persuade me, 
which I appreciated. (3025).
Strategy 2 chosen by oncologists: option of no anti‑cancer 
treatment is a sensitive issue & is used to influence patients
The discussion of ‘no anti-cancer treatment’ was a sen-
sitive issue. Some oncologists always mention it, as it is 
a realistic option. Others acknowledged that it was not 
always a logical option to discuss, especially for young 
patients with hormone-sensitive tumors. The option of 
no anti-cancer treatment was explicitly discussed where 
the burdens of anti-cancer treatment might outweigh 
the gains (e.g., with older patients, limited prognosis, 
sole option of chemotherapy). Introducing the option 
(or not introducing it) was used to influence patients’ 
decision-making.
For patients with hormone-sensitive tumors, you 
can usually find a treatment with relatively few 
side effects. Then it’s less obvious to me to suggest 
the option of no anti-cancer treatment. So I don’t 
know if I always mention it (…). But I do if I have a 
treatment in mind that won’t be symptom-free (…), 
or if the costs and benefits could be out of balance. 
(4009).
Patients’ preferences: option of no‑anti‑cancer treatment 
is a sensitive issue
Patients’ – sometimes strongly expressed – views varied 
on whether this option should be discussed. For some it 
was a realistic option that should always be mentioned; 
for others it equaled the end of available treatments. For 
most, this option was not relevant at that time. They 
knew, however, that it was an option, which should 
be discussed in detail later in their disease trajectory 
(e.g. when fewer options are available, or quality of life 
becomes impaired).
I do think we should have a choice. Those drugs have 
Fig. 2 Schematic overview of challenges; oncologists’ used strategies & patient preferences; possible facilitating role of expectancy & empathy
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a lot of side effects (…), so it has to be a choice (3042).
We didn’t discuss it [the option of no anti-cancer 
treatment, ed.], because I had already said that 
wasn’t an option. I want to continue as long as pos-
sible. (3010).
Challenge: How to approach discussing side effects
A last challenge is how to discuss possible side effects.
Strategy chosen by oncologists: different routes to complete 
information
Oncologists described several approaches, but ultimately 
favored full side-effect insight. Most oncologists men-
tioned common and alarming side effects (more would 
be overwhelming); a few mentioned all possible side 
effects (to inform the patient fully and protect against 
later complaints); some always mentioned specific side 
effects (e.g. nausea). Oncologists considered it impor-
tant for patients ultimately to be fully informed – possi-
bly through specialized nurses/written information – to 
make well-informed decisions. The impact of treatments 
on patients’ daily functioning was also sometimes men-
tioned, but patients’ priorities were seldom explored.
We try to mention the most important things. In the 
case of chemotherapy, they also talk to a nurse who 
informs them about almost all possible side effects, 
and often provides the information on paper as well. 
(4007).
And I always add a bit about what I often see. And 
how hard people usually find it (…). And I always 
discuss the important things, like when they should 
contact us, or dangerous side effects (…). When it 
comes to choosing treatment A or B, I also discuss 
the risk of side effects that will really impact quality 
of life. (4025).
Patients’ preferences: variety in preferences 
regarding complete information
Patients’ view on the ‘right’ approach for side-effect infor-
mation also varied. Most patients wanted to be informed 
of alarming side effects. Preferences varied about 
whether all side effects should be mentioned, or the most 
common, personally relevant, or only a limited number. 
The opportunity to contact the hospital was important; 
written information and concrete advice on handling 
side effects was seen as less essential. Most patients were 
reluctant to receive statistical side-effect information 
which might not apply to the individual.
I think they should provide clear guidelines for when 
it is red alert (…). If you experience this, call imme-
diately and go straight to hospital (3020).
If they had given me the whole list of what could 
happen I would have never started it, and in hind-
sight I’m glad I did. (3051).
That’s why I say: every person responds differently 
(…). I um, no I don’t really believe in numbers. 
(3034).
The facilitating role of expectancy
When introducing the topic of positive expectations, 
patients and oncologists stressed the importance of real-
ism. Still, positive expectations can facilitate addressing 
the challenges encountered, by influencing decision-mak-
ing, easing patients’ disease burden, and creating space.
Influencing decisions: oncologists
Oncologists spoke about how they use positivity to influ-
ence treatment decision-making by highlighting benefits, 
(dis)advantages, and side effects. For example, potential 
positive outcomes are stressed early in the disease trajec-
tory, while disadvantages are highlighted when oncolo-
gists think it might be better to stop intensive treatments.
If you feel you have little faith in the treatment, 
you’re perhaps more inclined to highlight how hard 
it is, whereas if you feel it’s a very important treat-
ment, you indicate more that it’s not that bad. 
(4018).
Easing disease burden: oncologists
Some oncologists acknowledged that positive expecta-
tions can influence how patients cope and experience 
symptoms and side effects. Positivity was sometimes 
explicitly used to motivate patients, e.g. to start/continue 
treatments.
If people are nauseous from chemo, and I give them 
a remedy, I’ll add that it works really well. Because I 
know this can give just that extra placebo effect that 
stops them feeling nauseous. (4009).
Especially chemotherapy – many patients really 
dread it. So I explain that there are many sorts of 
chemo, and this one really isn’t so bad usually. 
(4025).
Creating space: oncologists
Oncologists seldom explicitly mention that positive 
expectations can create space, but focus on balancing 
between discussing potential positive and negative out-
comes/side effects.
So I talk about side effects, but immediately add 
that almost nobody has all side effects, and it var-
ies – from people with almost none to people who do 
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experience many side effects. (4039).
Creating space: Patients
Patients focused on how positive expectations can create 
space. They often mentioned the importance of receiving 
information about possible positive treatment outcomes 
and limited side effects. For some this needed to be bal-
anced against potential negative outcomes (more realis-
tic); others preferred a focus on positivity (something to 
aim for); some acknowledged they realized themselves 
things might not go well. 
…that they inform you it may not have much effect, 
or may not agree with you; but possibly you will 
respond very well; we just have to try it out, because 
it differs per person. (3025).
Maybe a doctor can help at that point. Maybe it 
would work, (…). Without fibbing. Just saying ‘it’s 
possible’. Who knows, let’s just try. (3028).
Hearing about possible anti-cancer treatment options 
was described as ‘positive’, especially knowing that there 
are options available if the present treatment fails.
Say the tumors start growing, or the blood levels 
aren’t good, or whatever… that there are still drugs 
they can try. This drug isn’t the end of the road. And 
I like that she keeps repeating that, let’s say. (…) 
That [creating space, ed.] is really important for me. 
(3042).
The facilitating role of empathy
Oncologists see empathy (see Table  2 for the faces of 
empathy) as the basis for their communication, while 
acknowledging that it depends on the patient, situation, 
and doctor-patient relationship.
It is easier to feel empathy with someone you find 
likable than someone who actually evokes irritation. 
(4018).
Table 2 Different faces of empathy
Of course it has to do with my illness, but I’d rather he [the oncologist, ed.] focused on my treatment and everything related to it. I’ll find other help for the psychological side of 
things. (3010)
Oncologists
Oncologists did not always find it easy to cite concrete examples of how they demonstrate empathy. Still, they did sometimes mention examples of 
empathic behavior. Firstly, they could think things through with the patient, but from a medical perspective (e.g., suggesting that a daughter get mar-
ried earlier so her mother could still attend). Secondly, they could reassure the patient that they would not be abandoned (e.g., telling patients that the 
medical team would do their utmost). Thirdly, they could state how sorry they feel for patients
And in that way you can give some kind of positive turn to giving that really bad news—because I’d known her for some time, you see. (…) How was it [the wed-
ding, ed.]? It was great. And now she’s going downhill, but she is very grateful to me for saying she should move the wedding forward. (4034)
It’s bad enough having to explain to someone that he is incurable ill, but if you say (…) we’re there for you to tackle problems and answer questions, in short, to 
support you and help you, that does help a bit. I think people do feel a lot better when they go through that door. (4012)
And certainly if there is anguish, I really feel for them, and I express in words that I empathize with them. (4039)
Patients
Patients spoke in detail about the different forms of empathy oncologists could express, based on realistic foundations. Firstly, they highly appreciated 
the oncologist thinking things through with them from a medical and a practical perspective: for example, enquiring about the patient’s home situa-
tion and whether they need practical help, or trying to think about the best treatments in line with the patient’s preferences
Right at the start our oncologist asked why we didn’t have home help. (…) So the fact that a doctor comes back to it like that, and says ‘think about it – you’re 
entitled to it’ (…) – that’s really great. But that’s what empathy is – thinking with the other person and imagining what you would feel yourself. (3018)
Secondly, they appreciated it if the doctor showed an interest in the patient and took them seriously, for example sincerely enquiring how patients and 
their loved ones were doing, asking about specific events such as holidays, considering patients’ thoughts, preferences, or symptoms seriously
We went to see him, and just after the diagnosis my husband got a tattoo, and he noticed. One time he was in the middle of a conversation, then he looks at my 
husband, and says “hey”, “you didn’t have that tattoo last time”, he says. And those are the kinds of things I think – oh, he sees. And I just like that about him – it’s 
genuine, and it shows you’re really interested. (3034)
And interest, and takes you seriously, and listens to what you say. Because that is, well, that’s always really important. That you have the feeling the doctor really 
wants to know how you are and what you think about something. (3018)
Thirdly, patients appreciated it if oncologists took enough time for conversations – especially difficult ones –, or at least gave the impression of having 
time and expressed a sense of calm
Even if she’s running an hour late, that she still gives you the feeling she has time for you. And that you can ask whatever you want. (…) Yes, she radiates a sense 
of calm, I feel (3042)
Lastly, they did not seem to expect oncologists to provide specific psychological assistance, which they sought from other sources, such as specialized 
nurses, psychologists, or fellow patients
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Patients see expressions of empathy as important, but 
with a firm medical basis: the oncologists’ medical exper-
tise is paramount. A lack of empathy was perceived as 
hurtful.
Let’s say [the medical part, ed.] 75%, and the per-
sonal part 25%; asking how I’m doing, how things 
are at home (…). And it’s not strictly necessary, 
because basically I’m there for my disease and not to 
make friends. (3034).
However, although this is not mentioned as explicitly 
as for expectancy, oncologists’ expressions of empathy 
may facilitate the process of addressing the challenges 
encountered, by helping patients to open up (e.g. about 
their thoughts, feelings, priorities, personal situation), 
thus allowing information and care to be tailored to their 
needs.
Helping patients to open up and tailoring information 
and care: oncologists
Some oncologists mentioned that expressions of empathy 
can lead patients to open up and confide their priorities. 
This in turn may facilitate the provision of person-cen-
tered information and – treatment – care.
Because the better you think you understand the 
other, the more there’s a click, let’s say – that means 
you understand one another better and you can get 
closer to the core of those people, what motivates 
that person? And what is important to that person? 
Yes, I do believe the better you can unearth that, the 
more carefully you can advise them. (4005).
Opening up: patients
A few patients also stated that if an oncologist shows 
empathy, they are more willing to open up and share 
their feelings or story.
You have to feel comfortable with someone; you’re 
not going to reveal yourself to just anybody. If there’s 
some asshole of a surgeon opposite me, then I’m like 
whatever. Yes, you have to have someone you feel 
comfortable with. (3002).
Discussion
This study aimed to explore oncologists’ and patients’ 
views on challenges of providing information to women 
with advanced breast cancer, and possible strategies to 
address these challenges, meanwhile exploring the pos-
sible facilitating role of positive expectations and empa-
thy, with the ultimate aim to come to patient-centered 
care. Integrating oncologists’ and patients’ views, we 
observed that oncologists face challenges regarding 
handling unrealistic beliefs, and regarding choosing 
how to discuss treatment options (including no anti-
cancer therapy) and possible side effects. Strategies to 
address these challenges include balancing information-
provision with acceptance of denial, and using medical 
expertise to guide treatment discussions (though dis-
cussing the option of no anti-cancer therapy remains a 
sensitive issue). A variety of approaches and preferences 
for discussing side effects exists. Positive expectations 
and empathy can facilitate information-provision by – 
amongst others – creating space and helping patients to 
open up.
In general, oncologists reported more challenges in 
information-provision than patients. While patients are 
increasingly involved in agenda-setting [21], oncologists 
bear the responsibility for explaining complex medical 
information in a manner patients can understand [22]. 
This imbalance sheds light on the challenges and also 
strategies being formulated from the oncologists’ view-
points while they derived from both oncologists’ and 
patients’ data.
A first main challenge that arises in information-pro-
vision is handling patients’ unrealistic disease beliefs, 
mainly about the diseases incurability. While patients 
stressed the importance of realism, oncologists also 
leaned towards accepting denial. Previous studies have 
found that patients place great importance on realism 
[23–25]. Simultaneously, denial of a life-threatening diag-
nosis occurs in 4–47% of patients, can be temporary [26], 
and can serve as an adaptive coping mechanism [27]. The 
strategy endorsed by clinicians in our study (and beyond 
[28]) – accepting temporary denial after providing realis-
tic information – may be the best way to approach unre-
alistic beliefs.
A second core challenge is which treatment options to 
discuss: all or a selection. Patients and oncologists both 
mentioned that medical expertise is essential for selecting 
treatment options, while individuals held strong views on 
whether the option of no anti-cancer therapy should be 
mentioned. Previous research has found that oncologists 
want to discuss “best options” [29] – not always includ-
ing no-treatment [7, 30] – while patients have faith in 
oncologists’ treatment recommendations [12, 29, 31–33]. 
This seems to contradict legal requirements [34–36] and 
guidelines stressing the importance of mentioning all 
available treatment options [37], including solely optimal 
supportive care [22]. Perhaps such guidelines overlook 
patients’ need for medical guidance, and the emotional 
impact of raising the option of no anti-cancer therapy. In 
an era of increased focus on patients’ responsibility, we 
should not overlook the sensitivity of discussing no anti-
cancer treatment, and the importance of medical exper-
tise in guiding patients through difficult, uncertain times.
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A last challenge, with no clear solution, seems to be 
how to discuss potential side effects. Patients and oncolo-
gists agreed that alarming attention-requiring side effects 
should be discussed; however, while patients varied in 
their preferences regarding additional information on 
side effects, oncologists favored complete information-
provision. Given the ethical and legal requirements for 
“informed consent” [35–37] to be based on full infor-
mation and insight, oncologists’ perspectives are under-
standable. Some previous studies have found patients 
wishing to receive more [1, 38] and not too much [33] 
information on side effects. Our study suggests that 
above all information on serious side effects is appreci-
ated. Whether mild/nonspecific side effects should also 
always be discussed remains unanswered. Moreover, the 
variety in patients’ preferences regarding the discussion 
of side-effects (and treatment options), once again high-
lights the importance of adjusting information to each 
individual patients’ needs and preferences, in order to 
come to patient-centered care. In order to tailor informa-
tion, oncologists have been advised to ask patients about 
their information-preferences [39].
Next, we also explored the roles of positive expecta-
tions and empathy in facilitating information-provision. 
For patients, positive expectations might provide hope, 
as stressing potential positive outcomes and treatment 
options has previously been described as hopeful [12, 24, 
25]. For oncologists, who seem regularly to mention pos-
sible positive treatment outcomes [40], stressing poten-
tial advantages or disadvantages can serve as a tool to 
influence decision-making, as also previously found [30]. 
In this earlier study, oncologists acknowledged to some-
times provide information regarding hams and benefits 
in line with their preferred (treatment) option. It remains 
to be determined whether, as suggested in our study, pos-
itive expectations can ease disease burden in advanced 
cancer; positive effects on non-cancer symptoms have 
been described [13, 14] while it might also improve cop-
ing and thereby symptom burden [41].
Where empathy is concerned, some oncologists and 
patients agreed it can prompt patients to share personal 
preferences and information, which oncologists can use 
to tailor information and care plans. In this regard, we 
could speculate that the trust patients placed in oncolo-
gists’ treatment plans may also have originated from 
empathy. Relationship-building and information-pro-
vision are often seen as distinct elements of the medical 
encounter [42, 43], but our study seems to question this. 
This view is supported by previous findings demonstrat-
ing that empathy can facilitate information-processing 
and improve patients’ recall [16–18]. Providing empathy 
need not be time-consuming [44, 45], with studies dem-
onstrating that effective empathy can be achieved in less 
than 40 s [16, 44]. It is a powerful, and often under-used 
[45], tool oncologists can use to make patients feel better 
[46, 47] and optimize information and care.
Our study has strengths and limitations. strengths 
mainly concern the often overlooked focus on chal-
lenges in information-provision and the dual focus on 
both patients’ and oncologists’ perspectives. Limitations 
mainly concern the generalizability of results beyond our 
study sample. Despite various attempts to include women 
with nonwestern migrant backgrounds and/or low edu-
cational level, mainly high-educated Caucasian women 
participated. Second, oncologists with a specific interest 
in communication might have participated, biasing our 
results.
Future studies might focus on how to tailor and match 
individual patients’ preferences – specifically on dis-
cussing the option of no anti-cancer treatment – with 
oncologists’ information-provision approaches. Assess-
ing patients’ information needs pre-consultation, as one 
oncologist suggested, might help. More insight is needed 
into how to inform patients about potential side effects 
in a way that is tailored to individuals’ preferences while 
adhering to information-provision obligations, and with-
out eliciting nocebo effects. In addition, we encourage 
future studies to be more culturally and health literate 
diverse, and to include males and other cancer types, as 
these variables might influence communication needs 
[48–51].
Conclusions
Integrating patients’ and oncologists’ views, oncologists 
can provide realistic information while also – temporar-
ily – accepting denial, and can use their medical exper-
tise when addressing challenges around unrealistic beliefs 
and the discussion of treatment options. Finding ways to 
tailor discussions of no anti-cancer treatment and side-
effect information are needed. Positive expectations and 
empathy might facilitate – tailored – information-pro-
vision, leading ultimately to patient-centered care at the 
heart of medicine.
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